Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Jul 30:16:100369.
doi: 10.1016/j.dadr.2025.100369. eCollection 2025 Sep.

A preliminary investigation of tobacco co-use on endocannabinoid activity in people with cannabis use

Affiliations

A preliminary investigation of tobacco co-use on endocannabinoid activity in people with cannabis use

Rachel A Rabin et al. Drug Alcohol Depend Rep. .

Abstract

Tobacco is commonly co-used with cannabis. This is unfortunate because tobacco co-use exacerbates select clinical consequences associated with cannabis use. Evidence demonstrates that low levels of anandamide, a prominent endocannabinoid, correlate with worse clinical outcomes. Fatty acid amide hydrolase (FAAH) degrades anandamide, and greater FAAH levels may underlie poorer clinical outcomes in people who co-use relative to those who use only cannabis. Therefore, we tested whether tobacco co-use increases FAAH levels beyond those associated with cannabis use alone. Cannabis-using participants (N = 13) were parsed into individuals with daily tobacco use (CT, n = 5) and no current tobacco use (CAN, n = 8). We evaluated group differences in FAAH, quantified using positron emission tomography and [11C]CURB, while controlling for sex and FAAH genotype in the prefrontal cortex, hippocampus, thalamus, sensorimotor striatum, substantia nigra, and cerebellum. A significant group x ROI interaction for [11C]CURB λk3 [F(5, 45)= 3.15, p = 0.016] emerged. Bonferroni-corrected post-hoc tests indicated greater FAAH levels in CT compared to CAN in the substantia nigra (p = 0.023, d=1.54) and cerebellum (p = 0.003, d=1.76), while a trend emerged in the sensorimotor striatum (p = 0.054, d=1.33). Preliminary findings suggest that tobacco co-use is associated with elevated FAAH activity relative to cannabis-only use, which may underlie poorer clinical outcomes associated with co-use.

Keywords: Anandamide; Cannabis; Co-use; Endocannabinoid; Fatty acid amide hydrolase; Tobacco.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Figures

Fig. 1
Fig. 1
Group Differences in FAAH Levels. [11C]CURB λk3 was higher in CT relative to CAN in all brain regions examined. Significant group differences for [11C]CURB λk3 emerged in the substantia nigra (p = 0.023, d=1.54), and cerebellum (p = 0.003, d=1.76), while a trend emerged in the sensorimotor striatum (p = 0.054, d=1.33). CAN, participants with cannabis-only use; Cer, cerebellum; CT, participants with cannabis-tobacco co-use Hipp, hippocampus; PFC, prefrontal cortex SMS, sensorimotor striatum; SN, substantia nigra; Thal, Thalamus. Means are adjusted for sex and FAAH genotype. Error bars represent standard error.
Fig. 2
Fig. 2
Association Between Cerebellar FAAH Levels and Tobacco Consumption Cerebellar [11C]CURB λk3 significantly correlated with cigarettes per day across all participants, (r = 0.65, p = 0.030). Values have been corrected for sex and genotype.

Similar articles

  • Prescription of Controlled Substances: Benefits and Risks.
    Preuss CV, Kalava A, King KC. Preuss CV, et al. 2025 Jul 6. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. 2025 Jul 6. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. PMID: 30726003 Free Books & Documents.
  • A multi-site study examining the tobacco withdrawal trajectory in people with tobacco and cannabis co-use.
    Rabin RA, Lerman C, Schnoll R, Tyndale RF, George TP. Rabin RA, et al. Drug Alcohol Depend. 2025 Sep 1;274:112778. doi: 10.1016/j.drugalcdep.2025.112778. Epub 2025 Jul 3. Drug Alcohol Depend. 2025. PMID: 40633181 Clinical Trial.
  • Cannabis and schizophrenia.
    McLoughlin BC, Pushpa-Rajah JA, Gillies D, Rathbone J, Variend H, Kalakouti E, Kyprianou K. McLoughlin BC, et al. Cochrane Database Syst Rev. 2014 Oct 14;2014(10):CD004837. doi: 10.1002/14651858.CD004837.pub3. Cochrane Database Syst Rev. 2014. PMID: 25314586 Free PMC article.
  • Interventions to reduce harm from continued tobacco use.
    Lindson-Hawley N, Hartmann-Boyce J, Fanshawe TR, Begh R, Farley A, Lancaster T. Lindson-Hawley N, et al. Cochrane Database Syst Rev. 2016 Oct 13;10(10):CD005231. doi: 10.1002/14651858.CD005231.pub3. Cochrane Database Syst Rev. 2016. PMID: 27734465 Free PMC article.
  • Interventions for tobacco use cessation in people living with HIV.
    Mdege ND, Shah S, Dogar O, Pool ER, Weatherburn P, Siddiqi K, Zyambo C, Livingstone-Banks J. Mdege ND, et al. Cochrane Database Syst Rev. 2024 Aug 5;8(8):CD011120. doi: 10.1002/14651858.CD011120.pub3. Cochrane Database Syst Rev. 2024. PMID: 39101506 Free PMC article.

References

    1. Adermark L. Modulation of endocannabinoid-mediated long-lasting disinhibition of striatal output by cholinergic interneurons. Neuropharmacology. 2011;61(8):1314–1320. - PubMed
    1. Agrawal A., Lynskey M.T. Tobacco and cannabis co-occurrence: does route of administration matter? Drug Alcohol Depend. 2009;99(1-3):240–247. - PMC - PubMed
    1. Agrawal A., Budney A., Lynskey M. The Co-occurring use and misuse of cannabis and tobacco: a review. Addiction. 2012;107:1221–1233. - PMC - PubMed
    1. American Psychiatric Association, 2000. Diagnostic and statistical manual of mental disorders (Revised 4th ed.). Author, Washington, DC.
    1. Baggio S., Deline S., Studer J., Mohler-Kuo M., Daeppen J.B., Gmel G. Routes of administration of cannabis used for nonmedical purposes and associations with patterns of drug use. J. Adolesc. Health. 2014;54(2):235–240. - PubMed

LinkOut - more resources